DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Genocea Biosciences, Inc. (GNCA)
« Back to company indexGNCA Chatter Timeline
Stock Ticker for GNCA
Most Active Tweeters for GNCA
| User | Tweets |
|---|---|
| @thejadedtrader | 10 |
| @bulletin_en | 3 |
| @DZalkowitz | 2 |
| @InsiderAlertsIA | 2 |
| @BlogYomi | 2 |
Recent Tweets for GNCA
 |
@UlmHi Codexis Inc. $GNCA Comparing side by side https://t.co/bq7JmMqiUw March 21st 2019, 6:03am |
 |
@bulletin_en Genocea Biosciences, Inc. $GNCA Ratings Summary on Mar 20, 2019 https://t.co/IkpOzLwOGi March 20th 2019, 8:03am |
 |
@InsiderAlertsIA $GNCA: New Insider Filing on SENIOR VP, PS&M NARINDERJEET SINGH: https://t.co/rwWe1NMs6a March 19th 2019, 10:03am |
|
@UlmHi Comparing of Flex Pharma Inc. $GNCA https://t.co/4uSCCWUl8V March 18th 2019, 7:03pm |
|
@InsiderAlertsIA $GNCA: New Insider Filing on President and CEO WILLIAM D CLARK: https://t.co/MLw1l2DkkO March 18th 2019, 1:03pm |
 |
@surveyist RT @thejadedtrader: $GNCA atlas neoantigen screen. How it works and why it’s better than AI derived screens. https://t.co/D9zGIPqtUX March 17th 2019, 10:03pm |
 |
@thejadedtrader $GNCA atlas neoantigen screen. How it works and why it’s better than AI derived screens. https://t.co/D9zGIPqtUX March 17th 2019, 7:03pm |
 |
@FinZTribune Genocea Biosciences Inc $GNCA Sellers Declined By 1.84% Their Shorts https://t.co/74X5vSpfUs March 16th 2019, 1:03pm |
|
@bulletin_en As of Mar 16, 2019 Genocea Biosciences Inc $GNCA Shorts Reduced By 1.84% https://t.co/Il7VoY1W7c March 16th 2019, 1:03pm |
 |
@whatsonthorold2 Time to Reconsider Genocea Biosciences Inc $GNCA After Less Short Sellers? https://t.co/IlsDLvnQbQ March 16th 2019, 8:03am |
 |
@BlogYomi Kitov Pharma Ltd $GNCA Comparing side by side https://t.co/GWUP6MSVkj March 16th 2019, 5:03am |
 |
@thefinreviewer CymaBay Therapeutics Inc. $GNCA Comparing side by side https://t.co/au7gG4gdpy March 15th 2019, 10:03pm |
 |
@reurope_stock How Many Genocea Biosciences, Inc. $GNCA's Analysts Are Bearish? https://t.co/MMT72Urffz March 15th 2019, 11:03am |
|
@BlogYomi Capricor Therapeutics Inc. $GNCA Contrasting side by side https://t.co/iBpKhpVG4r March 14th 2019, 7:03pm |
 |
@DZalkowitz @thejadedtrader $GNCA certainly has a similar multi-antigen approach like $MRKR - honestly, it's surprising that mo… https://t.co/boeMXkOwVt March 13th 2019, 2:03pm |
|
@thejadedtrader $GNCA gen-011 ACT asset will include exclusively Atlas derived ag’s. This approach will b most similar to $MRKR’s… https://t.co/1VgmkKu2Xr March 13th 2019, 1:03pm |
|
@thejadedtrader $GNCA slides from Cowen today. Genocea Biosciences (GNCA) Presents At Cowen and Company 39th Annual Health Care Con… https://t.co/ySLUaaWsEX March 13th 2019, 1:03pm |
 |
@SeekingAlpha $GNCA - Genocea Biosciences (GNCA) Presents At Cowen and Company 39th Annual Health Care Conference - Slideshow https://t.co/wuZSDu0qtq March 13th 2019, 1:03pm |
|
@thejadedtrader $GNCA “We know the right antigens to use (thanks to Atlas) vs our competition that use educated guesses”. Pretty m… https://t.co/qtqtC3ETbW March 13th 2019, 1:03pm |
|
@thejadedtrader $GNCA at Cowen today. Webcast: https://t.co/ZOis8elma7 March 13th 2019, 1:03pm |
|
@DZalkowitz @thejadedtrader I own both $GNCA and $MRKR, with MRKR being one of my largest holdings given no toxicity, inexpensi… https://t.co/rZTcITG6Ib March 12th 2019, 2:03pm |
|
@thejadedtrader $GNCA 011 asset sounds like they want to do what $MRKR is already doing but just 5yrs behind MRKR. Would b a great… https://t.co/d93SstfniB March 12th 2019, 2:03pm |
|
@thejadedtrader If NEA could get a merger between $GNCA and $MRKR that would create a best in breed ACT player. Would get much > a… https://t.co/iktmeNydds March 12th 2019, 1:03pm |
|
@thejadedtrader RT @ledgetop: $GNCA presenting at Cowen conference 3/13: https://t.co/Dl03WDwsyH March 12th 2019, 11:03am |
 |
@ledgetop $GNCA presenting at Cowen conference 3/13: https://t.co/Dl03WDwsyH March 12th 2019, 10:03am |
|
@thejadedtrader RT @jayabacus: @thejadedtrader Bought a position in $GNCA, with tight 80% institutional ownership spread across 4 tier one companies. Float… March 11th 2019, 11:03am |
 |
@jayabacus @thejadedtrader Bought a position in $GNCA, with tight 80% institutional ownership spread across 4 tier one compani… https://t.co/P18hnEFc0R March 11th 2019, 10:03am |
|
@thejadedtrader $GNCA (related) MIT Technology Review’s conversation with Gates regarding the future of cancer vaccines https://t.co/9kLT7RspBB March 10th 2019, 10:03am |
 |
@ChartMill $GNCA: The EPS growth is accelerating: in the next 2 years the growth will be better than in the last years.… https://t.co/sOA4QA8Hmd March 9th 2019, 5:03pm |
|
@bulletin_en Genocea Biosciences Inc $GNCA Shares Shorted Decreased By 1.84% https://t.co/GP8E5GQPcA March 8th 2019, 4:03pm |
 |
@Madeforprofit1 $GNCA and $LIFE next week presentation- next week mania , get in now???? https://t.co/wGBFZq32oY March 8th 2019, 9:03am |
 |
@ConsumerFeed Genocea Biosciences $GNCA Upgraded to “Buy” at Zacks Investment Research https://t.co/VIWN5xu3tM March 8th 2019, 4:03am |
 |
@northenwhite $BPTH $GNCA great plays March 7th 2019, 3:03pm |
 |
@GenoceaBio $GNCA welcomes Diantha Duvall as our new Chief Financial Officer. The team is thrilled to have Diantha onboard. https://t.co/fpobzrVVyc March 7th 2019, 3:03pm |
|
@InsiderAlertsIA $GNCA: New Insider Filing on CHIEF FINANCIAL OFFICER DIANTHA DUVALL: https://t.co/JAh0btCOYs March 7th 2019, 3:03pm |
|
@Madeforprofit1 $LIFE and $GNCA presentation next week - get ready for next week 100% move easily???? https://t.co/vRLNpWAyl2 March 7th 2019, 12:03pm |
|
@Madeforprofit1 $LIFE and $GNCA presentation next week - get ready for next week 100% move easily?? https://t.co/9yEv1RH7KG March 7th 2019, 12:03pm |
 |
@registrarjourn Genocea Biosciences $GNCA Rating Increased to Buy at Zacks Investment Research https://t.co/NhgO16wUrf March 7th 2019, 5:03am |
 |
@EnterpriseLeade Genocea Biosciences $GNCA Rating Increased to Buy at Zacks Investment Research https://t.co/ny5E529Qpi March 7th 2019, 5:03am |
 |
@LifeSciAdvisors Genocea $GNCA to Present at the Cowen & Company 39th Annual Health Care Conference https://t.co/wIsIAJECSW March 6th 2019, 6:03pm |
|
@thejadedtrader RT @StockTexts: $GNCA Genocea to Present at the Cowen & Company 39th Annual Health Care Conference Nasdaq:GNCA https://t.co/C9iwEQurfi March 6th 2019, 8:03am |
 |
@StockTexts $GNCA Genocea to Present at the Cowen & Company 39th Annual Health Care Conference Nasdaq:GNCA https://t.co/C9iwEQurfi March 6th 2019, 8:03am |
 |
@dispatchtribune TRACON Pharmaceuticals $TCON & Genocea Biosciences $GNCA Head-To-Head Analysis https://t.co/R5mnT08wgH March 6th 2019, 4:03am |
|
@dispatchtribune Genocea Biosciences $GNCA Rating Increased to Buy at Zacks Investment Research https://t.co/H0E2mLLmuK March 6th 2019, 2:03am |
 |
@OlympiaReport Genocea Biosciences $GNCA Rating Increased to Buy at Zacks Investment Research https://t.co/PP3aof754R March 6th 2019, 2:03am |
|
@surveyist RT @thejadedtrader: $GNCA has a 1 of a kind antigen screen that will prove essential 4 personalized autologous vaccines and ACTs. NEA is i… March 5th 2019, 10:03pm |
 |
@titan_v16 RT @thejadedtrader: $GNCA. Biotech Companies Intensify Research Into New Therapies to Combat Cancer https://t.co/3tpNUQbLgG March 5th 2019, 8:03pm |
|
@thejadedtrader $GNCA. Biotech Companies Intensify Research Into New Therapies to Combat Cancer https://t.co/3tpNUQbLgG March 5th 2019, 8:03pm |
|
@thejadedtrader $GNCA has ~100MM shares outstanding. ~85% of outstanding is owned by institutions and insiders. If they do a 10:1… https://t.co/eHegRewdUu March 5th 2019, 8:03pm |
|
@thejadedtrader $GNCA has a 1 of a kind antigen screen that will prove essential 4 personalized autologous vaccines and ACTs. NEA… https://t.co/MsTIDzqadY March 5th 2019, 6:03pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.